Development and characterization of an enhanced nonviral expression vector for electroporation cancer treatment

Kay, 2011, State-of-the-art gene-based therapies: the road ahead, Nat Rev Genet, 12, 316, 10.1038/nrg2971 Miest, 2014, New viruses for cancer therapy: meeting clinical needs, Nat Rev Microbiol, 12, 23, 10.1038/nrmicro3140 Fischer, 2005, Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome, Bull Acad Natl Med, 189, 779 Tomanin, 2004, Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction, Curr Gene Ther, 4, 357, 10.2174/1566523043346011 Nair, 2008, Retrovirus-induced oncogenesis and safety of retroviral vectors, Curr Opin Mol Ther, 10, 431 Davidson, 2000, Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system, Proc Natl Acad Sci USA, 97, 3428, 10.1073/pnas.97.7.3428 Niidome, 2002, Gene therapy progress and prospects: nonviral vectors, Gene Ther, 9, 1647, 10.1038/sj.gt.3301923 Thomas, 2003, Progress and problems with the use of viral vectors for gene therapy, Nat Rev Genet, 4, 346, 10.1038/nrg1066 Pérez-Martínez, 2011, Barriers to non-viral vector-mediated gene delivery in the nervous system, Pharm Res, 28, 1843, 10.1007/s11095-010-0364-7 Morille, 2008, Progress in developing cationic vectors for non-viral systemic gene therapy against cancer, Biomaterials, 29, 3477, 10.1016/j.biomaterials.2008.04.036 Gill, 2009, Progress and prospects: the design and production of plasmid vectors, Gene Ther, 16, 165, 10.1038/gt.2008.183 Sheridan, 2011, Gene therapy finds its niche, Nat Biotechnol, 29, 121, 10.1038/nbt.1769 Caracò, 2013, Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis, BMC Cancer, 13, 564, 10.1186/1471-2407-13-564 Spugnini, 2013, Electrochemotherapy for the treatment of recurring aponeurotic fibromatosis in a dog, Can Vet J, 54, 606 Campana, 2012, The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study, Breast Cancer Res Treat, 134, 1169, 10.1007/s10549-012-2095-4 Salwa, 2014, Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management, J Plast Reconstr Aesthet Surg, 67, 403, 10.1016/j.bjps.2013.07.019 Jahangeer, 2013, Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours, Cancer Treat Rev, 39, 862, 10.1016/j.ctrv.2013.03.007 Escoffre, 2012, Electrochemotherapy: progress and prospects, Curr Pharm Des, 18, 3406, 10.2174/138161212801227087 Weaver, 1993, Electroporation: a general phenomenon for manipulating cells and tissues, J Cell Biochem, 51, 426, 10.1002/jcb.2400510407 Daud, 2008, Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma, J Clin Oncol, 26, 5896, 10.1200/JCO.2007.15.6794 Spanggaard, 2013, Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study, Hum Gene Ther Clin Dev, 24, 99, 10.1089/humc.2012.240 Cemazar, 2006, Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?, Curr Pharm Des, 12, 3817, 10.2174/138161206778559740 Miklavcic, 1998, The importance of electric field distribution for effective in vivo electroporation of tissues, Biophys J, 74, 2152, 10.1016/S0006-3495(98)77924-X Cemazar, 2012, Hyaluronidase and collagenase increase the transfection efficiency of gene electrotransfer in various murine tumors, Hum Gene Ther, 23, 128, 10.1089/hum.2011.073 Markelc, 2012, Muscle gene electrotransfer is increased by the antioxidant tempol in mice, Gene Ther, 19, 312, 10.1038/gt.2011.97 Sabri, 1998, Ascorbate increases electrotransformation efficiency of intact maize cells, Anal Biochem, 264, 284, 10.1006/abio.1998.2878 Atkins, 1999, The molecular pathogenesis of Semliki Forest virus: a model virus made useful?, J Gen Virol, 80, 2287, 10.1099/0022-1317-80-9-2287 Rayner, 2002, Alphavirus vectors and vaccination, Rev Med Virol, 12, 279, 10.1002/rmv.360 Kääriäinen, 2002, Functions of alphavirus nonstructural proteins in RNA replication, Prog Nucleic Acid Res Mol Biol, 71, 187, 10.1016/S0079-6603(02)71044-1 Ehrengruber, 2002, Alphaviral gene transfer in neurobiology, Brain Res Bull, 59, 13, 10.1016/S0361-9230(02)00858-4 Miklavcic, 2010, Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy, Biomed Eng Online, 9, 10, 10.1186/1475-925X-9-10 Miklavčič, 2012, Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors, Med Biol Eng Comput, 50, 1213, 10.1007/s11517-012-0991-8 Wang, 2014, In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses, J Virol, 88, 1924, 10.1128/JVI.02757-13 Heller, 2011, Electroporation based gene therapy–from the bench to the bedside, Conf Proc IEEE Eng Med Biol Soc, 2011, 736 Heller, 2000, In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity, Melanoma Res, 10, 577, 10.1097/00008390-200012000-00010 Heller, 2010, Electroporation gene therapy preclinical and clinical trials for melanoma, Curr Gene Ther, 10, 312, 10.2174/156652310791823489 Soden, 2006, Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours, Cancer Lett, 232, 300, 10.1016/j.canlet.2005.03.057 Goidin, 2001, Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations, Anal Biochem, 295, 17, 10.1006/abio.2001.5171